3 NEWS : Many cancer drugs remain unproven 5 years after accelerated approval, a study finds - The Associated Press #NewYork #news
- Many cancer drugs remain unproven 5 years after accelerated approval, a study finds The Associated Press
- Half of cancer drugs given accelerated approval fail in later trials - STAT STAT
- Speedier drug approvals hit slowdown as FDA faces scrutiny The Associated Press
- Scripps News-ProPublica investigation sparks Michigan cancer drug bill Scripps News
- Study: Few FDA-approved targeted cancer drugs meet ESMO benefit benchmarks Regulatory Focus
Publicar un comentario